止咳药市场：依疾病类型、药物类型、产品类型、年龄层、通路及地区划分

预计到 2026 年，止咳药市值将达到 15.246 亿美元，预计到 2033 年将达到 19.661 亿美元，2026 年至 2033 年的复合年增长率为 3.7%。

咳嗽是各种上呼吸道和下呼吸道感染疾病最常见的症状之一。它影响着许多人，也是人们就医的常见原因。根据《印度医学协会杂誌》2016年发表的数据，咳嗽是医院门诊就诊的第六大常见原因。止咳药（也称为镇咳药）是帮助抑制咳嗽的药物。止咳药的例子包括Dextromethorphan、可待因、那可汀、丁胺醇、Benzonatate和Pholcodine。Dextromethorphan和可待因是市面上最常用、应用最广泛的止咳药。

市场动态

主要企业频繁推出新型止咳药预计将推动止咳药市场在预测期内成长。例如，2018年3月，Perrigo公司获得FDA核准，其品牌非处方药Mucinex DM Maximum Strength（癒创甘油醚和Dextromethorphan缓释片，1200毫克/60毫克）上市。 Mucinex DM Maximum Strength能有效止咳化痰，促进排放排出。

市场上的主要企业正在进行咳嗽药物的安全性和有效性的研究和评估，预计这些努力将促成新型止咳药的开发。

例如，石药集团中奇药业技术有限公司正在评估Benzonatate软胶囊对改善成人咳嗽症状的疗效和安全性，目前正在进行第 3 期临床试验（2018 年）。

此外，咳嗽的高发生率预计将导致对止咳药的需求增加，从而推动市场成长。例如，根据美国国家生物技术资讯中心2013年发表的一项研究，咳嗽是一种非常常见的症状，英国约有12%的人每天或每週都会经历慢性咳嗽。

本次调查的主要特点

• 本报告对咳嗽药市场进行了详细分析，并以 2025 年为基准年，给出了预测期（2026-2033 年）内的市场规模和復合年增长率。
• 它还重点介绍了各个细分市场的潜在商机，并解释了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
• 该研究根据以下参数介绍了全球止咳药市场主要企业的概况：公司概况、财务表现、产品系列、地理扩张、分销策略、关键发展和策略以及未来计划。
• 本报告的研究结果将帮助负责人和经营团队就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球止咳药市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 透过分析止咳药市场的各种策略矩阵，相关人员可以轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监管与趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • PEST分析
  • 波特五力分析
  • 市场机会
  • 法规环境
  • 重大进展
  • 产业趋势

4. 2026-2033年全球止咳药市场（依疾病类型划分）

• 干咳
• 湿咳

5. 2026-2033年全球止咳药市场（依药物类型划分）

• Dextromethorphan
• 可待因
• 诺斯卡品
• 布塔米拉特
• Benzonatate
• Pholcodine
• 其他的

6. 2026-2033年全球止咳药市场（依产品类型划分）

• 非处方药
• 处方药

7. 2026-2033年全球止咳药市场依年龄层划分

• 儿童
• 成人

8. 2026-2033年全球止咳药市场（依通路划分）

• 医院
• 零售药房
• 网路药房
• 其他的

9. 2026-2033年全球止咳药市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十章 竞争格局

• 热图分析
• 市占率分析（3x3矩阵）
• 公司简介
  • Perrigo Company plc
  • Vernalis plc
  • Tris Pharma Inc.
  • Pfizer Inc.
  • Aytu BioScience, Inc.
  • Acella Pharmaceuticals LLC
  • Mayne Pharma Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd
  • GlaxoSmithKline plc.

第十一章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章各节

• 参考
• 调查方法

Cough Suppressant Drugs Market is estimated to be valued at USD 1,524.6 Mn in 2026 and is expected to reach USD 1,966.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.7% from 2026 to 2033.

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market.

Market Dynamics

Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive.

Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs.

For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial.

Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly.

Key features of the study

• This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global cough suppressant drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market

Market Segmentation

• Disease Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Dry Cough
  • Wet Cough
• Drug Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butamirate
  • Benzonatate
  • Pholcodine
  • Others
• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Over-the-counter (OTC)
  • Prescription Drug
• Age Group Insights (Revenue, USD Mn, 2026 - 2033)
  • Pediatric
  • Adult
• Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Perrigo Company plc
  • Vernalis plc
  • Tris Pharma Inc.
  • Pfizer Inc.
  • Aytu BioScience, Inc.
  • Acella Pharmaceuticals LLC
  • Mayne Pharma Inc.
  • Taro Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd
  • GlaxoSmithKline plc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Disease Type
  • Market Snippet, By Drug Type
  • Market Snippet, By Product Type
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Cough Suppressant Drugs Market, By Disease Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Dry Cough
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Wet Cough
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Cough Suppressant Drugs Market, By Drug Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Dextromethorphan
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Codeine
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Noscapine
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Butamirate
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Benzonatate
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pholcodine
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Cough Suppressant Drugs Market, By Product Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Over-the-counter (OTC)
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Prescription Drug
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Cough Suppressant Drugs Market, By Age Group, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pediatric
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Adult
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Retail Pharmacy
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Online Pharmacy
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

9. Global Cough Suppressant Drugs Market, By Region, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Perrigo Company plc
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Vernalis plc
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Tris Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Pfizer Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Aytu BioScience, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Acella Pharmaceuticals LLC
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Mayne Pharma Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Taro Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Amneal Pharmaceuticals LLC
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Aurobindo Pharma Ltd
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • GlaxoSmithKline plc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. Section

• References
• Research Methodology
• About Us and Sales Contact